Skip to content

A Study on Dashamula Trivrutta Snehapana for Relief from Period Pain in Females Aged 15 25 Years

A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Dashamula Trivrutta Snehapana in Udavartini Yonivyapada with Reference to Primary Dysmenorrhea Among 15-25 Years Old Female - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112364
Enrollment
60
Registered
2026-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Sponsors

Dr vaishnavi Shamrao Korde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with Udavarta Yonivyapad (dysmenorrhea as per Ayurvedic and modern criteria). Regular menstrual cycles. Willing to provide informed consent.

Exclusion criteria

Exclusion criteria: Patient of age group below 15 and above 25 years. patient of pelvic pathology i.e PID,PCOD, Cervical stenosis, Fibroid,Endometriosis,DUB, Adenomyosis, Endometrial polyps. PCOS, hypothyroidism, or other systemic illness . Use of hormonal contraceptives or intrauterine devices. Pregnancy or lactation. -Patient with congenital anomalies of reproductive system -Mennorahgia

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Dashamula trivrutta Sneha pana given for 7 days of age 15 to 25 year is statistically effective in Udavartini Yonivyapada with reference to primary dysmenorrheaTimepoint: After treatment 1st menstrual cycle After treatment 2nd menstrual

Secondary

MeasureTime frame
1.To evaluate Udavartini Yonivyapada according to ayurveda. 2.To evaluate primary dysmenorrhea to modern perspective 3.To assess the properties of Dashamula trivrutta Sneha pana in relation to Udavartini Yonivyapada. 4.To compare the effect of Dashamula trivrutta Sneha pana and cyclopam in the management of Udavartini Yonivyapada with reference to Primary Dysmenorrhea. 5.To observe adverse drug reaction is anyTimepoint: After treatment 1st menstrual cycle After treatment 2nd menstrual

Countries

India

Contacts

Public ContactDr Pallavi Chandanshiv

Yashvantrao Chavan Ayurvedic Medical College Aurangabad

vaishukorde1999@gmail.com9112711518

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026